Isoformix is a biotech company developing novel protein isoforms assays and discovering new therapeutic targets for Alzheimer's disease  

Isoformix has a suite of mass spectrometry-based assays targeting protein isoforms biomarkers with clinical significance in the development and progression of Alzheimer's disease

Isoformix is collaborating with clinical researchers around the world, using its proprietary technology and assays to provide new insights into the pathophysiology of Alzheimer's disease and to discover new therapeutic targets.